The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway

PURPOSE: This study was aimed at exploring the regulatory mechanism of Xiaoyao San (XYS) and its main compound, Stigmasterol, in the biological network and signaling pathway of ovarian cancer (OC) through network pharmacology-based analyses and experimental validation. METHODS: The active compounds...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Meng, Zhang, Wenqi, Yang, Linqi, Wang, Huibing, Wang, Yihan, Huang, Kai, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263223/
https://www.ncbi.nlm.nih.gov/pubmed/34306252
http://dx.doi.org/10.1155/2021/4304507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263223/
https://www.ncbi.nlm.nih.gov/pubmed/34306252
http://dx.doi.org/10.1155/2021/4304507

Ejemplares similares